BackAdvaxis Overview

Advaxis Receivables

Track Advaxis's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-234000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Advaxis Receivables History

Loading

Advaxis vs. peers: Receivables Comparison

Loading

Advaxis Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Advaxis (ADXS) FAQ

Advaxis (ADXS) currently reports a receivables of $0 as of December 2023. That compares with $230K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Advaxis's receivables history and peer comparisons.

Advaxis's receivables decreased from $230K to $0 — a 100.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Advaxis reported $0 in receivables as of December 2023. That compares with $230K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Advaxis, and consider following ADXS for alerts when major investors trade the stock.

Advaxis is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADXS with unrelated industries.